Home > Insider Trading > Filing (0001209191-10-035435)

Filing Details

Accession Number:: 0001209191-10-035435
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-23 13:00:00
Reporting Period:: 2010-06-21

Filing Date:: 2010-06-23
Accepted Time:: 2010-06-23 17:12:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1058190	F Bruce Wesson	C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-06-21	111,708	$24.15	5,562,927	No	4	S	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See FN

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	54,783	Direct

Footnotes

The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
The shares were sold as follows: 19,650 by Galen Partners IV, L.P. ("Galen IV"), 1,560 shares by Galen Partners International IV, L.P. ("Galen International IV"), 28 by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 82,692 by Galen Partners III, L.P. ("Galen III"), 7,494 by Galen Partners International III, L.P. ("Galen International III") and 284 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
The shares were sold at prices between $24.06 and $24.56. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 977,8872 by Galen IV, 77,682 by Galen International IV, 1,362 by Employee Fund IV, 4,115,239 by Galen III, 372,950 by Galen International III and 17,807 by Employee Fund III. Claudius IV, L.L.C. ("Claudius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
Claudius, L.L.C. ("Claudius") serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. The Reporting Person is a member of Claudius IV, a member of Claudius and the sole shareholder of Wesson Enterprises. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein.